Literature DB >> 9950284

Heterogeneous tube model for the study of small intestinal transit flow.

A Kalampokis1, P Argyrakis, P Macheras.   

Abstract

PURPOSE: A Monte-Carlo computer simulation technique was employed to study the details of the small intestinal transit flow in the gastrointestinal (GI) tract.
METHODS: A heterogeneous tube model was constructed using a numerical computer simulation technique. The model was built from first principles and included several heterogeneous characteristics of the GI tract structure. We used a random, dendritic-type internal structure representing the villi of the GI tract. The small intestinal transit flow was simulated using two diffusion models, namely, the blind ant and the myopic ant models, which are different models to account the elapse of time, and which are both based on statistical properties of random walks. For each one of the models we utilize two types of biased random walk, placing different emphasis in the motion towards the output of the tube. We monitored the flow of the drug in terms of Monte-Carlo time steps (MCS) through the tube walls and dendritic villi present.
RESULTS: The frequency of the transit times was dependent on the structure of the dendritic villi and on the type of biased random walk. The small intestinal flow profile of literature data for a large number of drugs was well characterized by the heterogeneous model using, as parameters, a certain number of villi per unit length of the tube and specific characteristics for both types of the biased random walk. A correspondence between the MCS and real time units was achieved.
CONCLUSIONS: The transit process of the oral dosage forms in the GI tract can be reproduced with the heterogeneous model developed. This model can be used to study GI absorption phenomena.

Mesh:

Year:  1999        PMID: 9950284     DOI: 10.1023/a:1018874913372

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  7 in total

Review 1.  Gastrointestinal drug absorption: is it time to consider heterogeneity as well as homogeneity?

Authors:  P Macheras; P Argyrakis
Journal:  Pharm Res       Date:  1997-07       Impact factor: 4.200

2.  The influence of variable gastric emptying and intestinal transit rates on the plasma level curve of cimetidine; an explanation for the double peak phenomenon.

Authors:  R L Oberle; G L Amidon
Journal:  J Pharmacokinet Biopharm       Date:  1987-10

3.  Mixing-tank model for predicting dissolution rate control or oral absorption.

Authors:  J B Dressman; D Fleisher
Journal:  J Pharm Sci       Date:  1986-02       Impact factor: 3.534

4.  Estimating the fraction dose absorbed from suspensions of poorly soluble compounds in humans: a mathematical model.

Authors:  D M Oh; R L Curl; G L Amidon
Journal:  Pharm Res       Date:  1993-02       Impact factor: 4.200

5.  Physicochemical model for dose-dependent drug absorption.

Authors:  J B Dressman; D Fleisher; G L Amidon
Journal:  J Pharm Sci       Date:  1984-09       Impact factor: 3.534

6.  A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability.

Authors:  G L Amidon; H Lennernäs; V P Shah; J R Crison
Journal:  Pharm Res       Date:  1995-03       Impact factor: 4.200

7.  Description and simulation of a multiple mixing tank model to predict the effect of bile sequestrants on bile salt excretion.

Authors:  P E Luner; G L Amidon
Journal:  J Pharm Sci       Date:  1993-03       Impact factor: 3.534

  7 in total
  8 in total

1.  A heterogeneous tube model of intestinal drug absorption based on probabilistic concepts.

Authors:  A Kalampokis; P Argyrakis; P Macheras
Journal:  Pharm Res       Date:  1999-11       Impact factor: 4.200

2.  A new mathematical model quantifying drug release from bioerodible microparticles using Monte Carlo simulations.

Authors:  Juergen Siepmann; Nathalie Faisant; Jean-Pierre Benoit
Journal:  Pharm Res       Date:  2002-12       Impact factor: 4.200

3.  A reappraisal of drug release laws using Monte Carlo simulations: the prevalence of the Weibull function.

Authors:  Kosmas Kosmidis; Panos Argyrakis; Panos Macheras
Journal:  Pharm Res       Date:  2003-07       Impact factor: 4.200

Review 4.  Advanced pharmacokinetic models based on organ clearance, circulatory, and fractal concepts.

Authors:  K Sandy Pang; Michael Weiss; Panos Macheras
Journal:  AAPS J       Date:  2007-06-29       Impact factor: 4.009

Review 5.  Drug absorption modeling as a tool to define the strategy in clinical formulation development.

Authors:  Martin Kuentz
Journal:  AAPS J       Date:  2008-08-27       Impact factor: 4.009

6.  The changing face of the rate concept in biopharmaceutical sciences: from classical to fractal and finally to fractional.

Authors:  Aristides Dokoumetzidis; Panos Macheras
Journal:  Pharm Res       Date:  2011-01-25       Impact factor: 4.200

7.  On an Unphysical Hypothesis of Bateman Equation and its Implications for Pharmacokinetics.

Authors:  Panos Macheras
Journal:  Pharm Res       Date:  2019-05-08       Impact factor: 4.200

8.  In silico modeling of non-linear drug absorption for the P-gp substrate talinolol and of consequences for the resulting pharmacodynamic effect.

Authors:  Marija Tubic; Daniel Wagner; Hilde Spahn-Langguth; Michael B Bolger; Peter Langguth
Journal:  Pharm Res       Date:  2006-08       Impact factor: 4.200

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.